Papillary Microcarcinoma
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: Papillary microcarcinoma (PMC) is increasing in incidence because of diagnosis by ultrasound‐guided fine‐needle aspiration cytology. Methods: Between January 1966 and December 1995, we treated 6019 patients with papillary cancer; among them, 2070 patients with PMC were studied. Results: PMC is essentially very similar to papillary cancer that is 11 mm or larger and has a very good prognosis. Smaller tumors and younger patients have a better prognosis. Among PMC, larger tumors (6–10 mm) recur in 14% at 35 years compared with 3.3% in patients with smaller tumors. Patients older than 55 years have recurrence in 40% at 30 years, with a worse prognosis than younger patients who have a recurrence rate of less than 10%. Extracapsular invasion by the primary tumor also has a higher recurrence rate. The majority of recurrences are in the neck. Therefore, annual ultrasound of the neck is effective for recurrence surveillance. Conclusion: Papillary microcarcinoma is similar to larger papillary carcinomas with tumor characteristics and age‐based recurrence rate that extends for many years, justifying long surveillance after surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ito, Y., Uruno, T., Nakano, K., Takamura, Y., Miya, A., Kobayashi, K., Yokozawa, T., Matsuzuka, F., Kuma, S., Kuma, K., et al. (2003) · Thyroid · doi:10.1089/105072503321669875 · Cited by 877 · cited 1×
“However, there is no consensus in the management of the disease, resulting in a wide spectrum of responses for this condition ranging from observation without treatment [1] to total thyroidectomy plus radioactive iodine treatment [2, 3].”
BackgroundChow, S., Law, S. C. K., Chan, J. K. C., Au, S., Yau, S., & Lau, W. (2003) · Cancer · doi:10.1002/cncr.11442 · Cited by 723 · cited 1×
“[8] also found that age was not a significant factor in predicting disease recurrence or survival for PMC.”
BackgroundIncreased Aggressiveness of Thyroid Cancer in Patients with Graves' Disease*
BELFIORE, A., GAROFALO, M. R., GIUFFRIDA, D., RUNELLO, F., FILETTI, S., FIUMARA, A., IPPOLITO, O., & VIGNERI, R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-830 · Cited by 295
Geographic pathology of occult thyroid carcinomas
Fukunaga, F. H., & Yatani, R. (1975) · Cancer · doi:10.1002/1097-0142(197509)36:3<1095::aid-cncr2820360338>3.0.co;2-9 · Cited by 295 · cited 2×
“Also, according to Fukunaga and Yatani [4], the incidence of occult thyroid carcinoma is significantly higher in Japan (28.4”
BackgroundInfluentialSingh, B., Shaha, A. R., Trivedi, H., Carew, J. F., Poluri, A., & Shah, J. P. (1999) · Surgery · doi:10.1067/msy.2099.101431 · Cited by 271 · cited 1×
“Patients with Hashimoto’s disease and PMC had a recurrence-free survival at 35 years that was better than those preoperatively diagnosed with a benign nodule and PMC [15].”
BackgroundDoes Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer
HALES, I. B., McElduff, A., Crummer, P., Clifton‐Bligh, P., Delbridge, L., Hoschl, R., Poole, A., Reeve, T. S., WILMSHURST, E. G., & Wiseman, J. C. D. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517381 · Cited by 160
Small Carcinomas of the Thyroid: A Long-term Follow-up of 867 Patients
Noguchi, S. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430140077021 · Cited by 152 · cited 3×
“In our previous report [6] we recommended TSH suppression to all postoperative PMC patients, but the majority of patients who did not have postoperative hypothyroidism discontinued medication within a few years.”
BackgroundMethodResultSelf-citationPelizzo, M. R., Boschin, I. M., Toniato, A., Pagetta, C., Piotto, A., Bernante, P., Casara, D., Pennelli, G., & Rubello, D. (2004) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000126625.17166.36 · Cited by 131 · cited 2×
“[17] recommended lobectomy plus TSH suppression in 1990.”
Treatment for Microcarcinoma of the Thyroid—Clinical Experience
Küçük, Ö., Tari, P., Tokmak, E., & Araş, G. (2007) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000257272.90126.3d · Cited by 70 · cited 1×
“However, there is no consensus in the management of the disease, resulting in a wide spectrum of responses for this condition ranging from observation without treatment [1] to total thyroidectomy plus radioactive iodine treatment [2, 3].”
BackgroundGood prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis
Vini, L., Hyer, S., Pratt, B., & Harmer, C. (1999) · Postgraduate Medical Journal · doi:10.1136/pgmj.75.881.169 · Cited by 40 · cited 2×
“Death resulting from papillary thyroid carcinoma is uncommon and is particularly rare in low-risk patients like PMC [9].”
BackgroundResult
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
“Although most micropapillary carcinomas may be incidental findings, a subset may be more clinically relevant, especially those >5 mm in diameter (54).”
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Shin, J. H., Baek, J. H., Chung, J., Ha, E. J., Kim, J.-H., Lee, Y. H., Lim, H. K., Moon, W.-J., Na, D. G., Park, J. S., et al. (2016) · Korean Journal of Radiology · doi:10.3348/kjr.2016.17.3.370 · Cited by 889
Randolph, G. W., Duh, Q.-Y., Heller, K. S., LiVolsi, V. A., Mandel, S. J., Steward, D. L., Tufano, R. P., & Tuttle, F. T. A. T. A. (2012) · Thyroid · doi:10.1089/thy.2012.0043 · Cited by 838
Progress in molecular-based management of differentiated thyroid cancer
Xing, M., Haugen, B. R., & Schlumberger, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60109-9 · Cited by 573
Sugitani, I., Toda, K., Yamada, K., Yamamoto, N., Ikenaga, M., & Fujimoto, Y. (2010) · World Journal of Surgery · doi:10.1007/s00268-009-0359-x · Cited by 519
Moon, W.-J., Baek, J. H., Jung, S. L., Kim, D. W., Kim, E. K., Kim, J. Y., Kwak, J. Y., Lee, J. H., Lee, J. H., Lee, Y. H., et al. (2011) · Korean Journal of Radiology · doi:10.3348/kjr.2011.12.1.1 · Cited by 473
Thyroid Incidentalomas: Epidemiology, Risk Stratification with Ultrasound and Workup
Russ, G., Leboulleux, S., Leenhardt, L., & Hegedüs, L. (2014) · European Thyroid Journal · doi:10.1159/000365289 · Cited by 218
Subclinical lymph node metastasis in papillary thyroid microcarcinoma: A study of 551 resections
So, Y. K., Son, Y.-I., Hong, S. D., Seo, M. Y., Baek, C.-H., Jeong, H.-S., & Chung, M. K. (2010) · Surgery · doi:10.1016/j.surg.2010.01.003 · Cited by 195
The Treatment of Thyroid Cancer With Radiofrequency Ablation
Pace-Asciak, P., Russell, J. O., & Tufano, R. P. (2022) · Techniques in Vascular and Interventional Radiology · doi:10.1016/j.tvir.2022.100825 · Cited by 29
Metadata
- Authors
- Noguchi, S., Yamashita, H., Uchino, S., & Watanabe, S.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2008-02-11
- Volume
- 32
- Issue
- 5
- Pages
- 747-753
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W3187962855
- Cited by
- 218
- References
- 11
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.